WNK2 and melanoma: Somatic mutations in putative melanoma driver genes including NRASQ61R, BRAFG421R and MAP2K1P124S, all key components of the mitogen-activated protein kinase (MAPK) pathway, were ubiquitously detected in all 41 regions, supporting the notion that somatic mutational heterogeneity is predominantly attributable to passenger mutations.